{"id":"W4399305082","doi":"10.1093/rheumatology/keae283","title":"Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA","year":2024,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université de Montréal; Osteoporosis Canada; University Health Network; Toronto General Hospital; University of Toronto; Institute of Health Services and Policy Research; Montreal Heart Institute","funders":"Eli Lilly Canada; Pfizer Canada; Novartis Pharmaceuticals Canada; Sandoz Canada; University of Toronto; Celgene; Sanofi; Amgen Canada; AbbVie Canada; Amgen; Pfizer; Teva Pharmaceutical Industries; Eli Lilly and Company","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Rituximab; Internal medicine; Observational study; Proportional hazards model; Hazard ratio; Propensity score matching; Golimumab; Adalimumab; Physical therapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01789273,0.0003961156,0.001078266,0.001994526,0.0006768858,0.001555035,0.001600857,0.0009047657,0.005013461],"category_scores_gemma":[0.05935302,0.0002990561,0.002572513,0.004502035,0.0007685774,0.000825523,0.0006586516,0.0009555207,0.0003662204],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007967556,"about_ca_system_score_gemma":0.01301884,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.488902,"about_ca_topic_score_gemma":0.5968091,"domain_scores_codex":[0.9886981,0.004958509,0.002001625,0.001081831,0.002699176,0.0005608053],"domain_scores_gemma":[0.8602067,0.06626449,0.04346021,0.006274343,0.02115649,0.002637652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005938366,0.00008783545,0.8231917,0.00758484,0.009146594,0.00008827295,0.0003291159,0.0006066972,0.00009566708,0.0006047545,0.00986423,0.1424619],"study_design_scores_gemma":[0.001374853,0.0005683653,0.9360073,0.0140576,0.01406868,0.0001484319,0.0005062061,0.001864241,0.0002306442,0.0005462741,0.03053956,0.00008783134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3536398,0.5900192,0.002606585,0.01346876,0.0007112928,0.000377652,0.02812728,0.00005677947,0.01099263],"genre_scores_gemma":[0.9146078,0.07311166,0.001086888,0.001942884,0.0004888609,0.00009189828,0.007907751,0.00001491,0.0007472502],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.511098,"threshold_uncertainty_score":0.9721125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03471332824196915,"score_gpt":0.2940061179840092,"score_spread":0.2592927897420401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}